Kimberly Clark (KMB)
NASDAQ:KMB
Top Page
Kimberly Clark
(NASDAQ:KMB)
Select Model
Select Model
Rating:61Neutral
Price Target:
$118.00
▲(22.15% Upside)
Action:ReiteratedDate:01/30/26
The score is primarily supported by strong cash generation, resilient margins, and constructive 2026 guidance, with valuation helped by a high dividend yield. These positives are tempered by elevated leverage and negative revenue momentum, while technical signals remain weak with the stock below key long-term moving averages and MACD negative.
Positive Factors
Free Cash Flow Strength
Kimberly‑Clark’s robust FCF (~$2.8B TTM and ~100% conversion) provides durable internal funding for dividends, debt reduction, and strategic M&A. Strong cash generation improves capital allocation optionality over the medium term and cushions execution of productivity and margin plans.
Negative Factors
Elevated Leverage
A high debt-to-equity ratio (~4.0x) reduces financial flexibility and increases vulnerability to market or cost shocks. Even with strong FCF, leverage constrains the company’s ability to absorb setbacks, slows deleveraging capacity, and limits optionality for larger strategic investments.
Read all positive and negative factors
Positive Factors
Negative Factors
Free Cash Flow Strength
Kimberly‑Clark’s robust FCF (~$2.8B TTM and ~100% conversion) provides durable internal funding for dividends, debt reduction, and strategic M&A. Strong cash generation improves capital allocation optionality over the medium term and cushions execution of productivity and margin plans.
Read all positive factors
Kimberly Clark (KMB) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$32.29B
Dividend Yield5.03%
Average Volume (3M)5.00M
Price to Earnings (P/E)16.6
Beta (1Y)0.15
Revenue Growth-10.04%
EPS Growth-23.41%
CountryUS
Employees38,000
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)1.86
Shares Outstanding331,925,780
10 Day Avg. Volume5,081,032
30 Day Avg. Volume4,997,345
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)22.37
Price to Sales (P/S)1.95
P/FCF Ratio20.50
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue2.25
Enterprise Value/Gross Profit6.32
Enterprise Value/Ebitda11.75
Forecast
1Y Price Target
$116.10Price Target Upside20.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)7.52
Revenue Forecast (FY)$17.42B
Kimberly Clark Business Overview & Revenue Model
Company Description
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care ...
How the Company Makes Money
Kimberly-Clark makes money primarily through the sale of its consumer and professional products. The company generates revenue through various key streams, including sales of personal care products (diapers, feminine care), consumer tissue product...
Kimberly Clark Key Performance Indicators (KPIs)
Any
Revenue by Geography
Breaks down revenue across different regions, revealing where Kimberly Clark is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Breaks down revenue across different regions, revealing where Kimberly Clark is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Data provided by:
The Fly
The FlyKimberly Clark Earnings Call Summary
Earnings Call Date:Jan 27, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Apr 28, 2026
Earnings Call Sentiment Positive
The call was optimistic and execution-focused: management highlighted sustained volume-plus-mix momentum, meaningful market share gains, industry-leading productivity (targeting ~6% productivity in 2026), a strong innovation pipeline, and strategic M&A (Kenview and IFP) that management expects will drive higher-growth, higher-margin outcomes. Offsets include near-term pricing/promotional pressure in North America, a quantified ~60 bps headwind from lost club distribution, prior-year input-cost shocks (~$200 million) that depressed 2025 margins, and choppy category demand in late 2025. Overall, management conveyed confidence in margin recovery and annual growth pacing (with acceleration in the back half of 2026) and reiterated medium-term margin targets (40% adjusted gross margin and 18–20% operating profit before decade-end).Positive Updates
Consistent Volume + Mix Growth
Eighth consecutive quarter of solid volume-plus-mix performance: Q4 volume-plus-mix up ~1.7% (two-year stack +3.6%). North America showed stronger momentum in Q4 (volume-plus-mix ~+2.1%; two-year stack ~+4.1%).
Negative Updates
North America Pricing and Promo Pressure
Price/mix deceleration in North America observed in 2025: management noted promotional dynamics and strategic price-pack investments that reduced price realization in the year; club mix (larger pack sizes) also dragged price per unit.
Read all updates
Q4-2025 Updates
Positive
Negative
Consistent Volume + Mix Growth
Eighth consecutive quarter of solid volume-plus-mix performance: Q4 volume-plus-mix up ~1.7% (two-year stack +3.6%). North America showed stronger momentum in Q4 (volume-plus-mix ~+2.1%; two-year stack ~+4.1%).
Read all positive updates
Company Guidance
Management guided 2026 organic sales to be in line with to ahead of the weighted global category (around 2% y/y), with North America and international personal care expected to grow in line with or ahead of their categories; net sales are expected to be roughly 50/50 H1/H2 with organic growth accelerating into the back half. They expect operating profit growth at the higher end of mid- to high-single digits, adjusted EPS (constant currency) roughly in line with 2025, gross productivity of about 6% in 2026, input costs largely flat (no repeat of the ~ $200m headwind from 2025), and expansion of gross and operating margins in 2026 while absorbing an approximate 60 basis‑point headwind from partial loss of North America club diaper distribution; longer‑term targets remain gross margin ≥40% and operating profit 18–20% before 2030. Management also reiterated an expected mid‑year close for the IFP transaction and a back‑half close for Kenview, subject to approvals.Kimberly Clark Financial Statement Overview
Summary
Income Statement
67
Positive
Balance Sheet
34
Negative
Cash Flow
71
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.22B | 20.06B | 20.43B | 20.18B | 19.44B |
| Gross Profit | 6.13B | 7.18B | 7.03B | 6.22B | 5.99B |
| EBITDA | 3.11B | 3.98B | 3.07B | 3.38B | 3.25B |
| Net Income | 2.02B | 2.54B | 1.76B | 1.93B | 1.81B |
Balance Sheet | |||||
| Total Assets | 17.23B | 16.55B | 17.34B | 17.97B | 17.84B |
| Cash, Cash Equivalents and Short-Term Investments | 688.00M | 1.02B | 1.09B | 427.00M | 270.00M |
| Total Debt | 7.17B | 7.92B | 8.11B | 8.55B | 8.70B |
| Total Liabilities | 15.57B | 15.57B | 16.28B | 17.27B | 17.10B |
| Stockholders Equity | 1.50B | 840.00M | 915.00M | 547.00M | 514.00M |
Cash Flow | |||||
| Free Cash Flow | 1.64B | 2.51B | 2.78B | 1.86B | 1.72B |
| Operating Cash Flow | 2.78B | 3.23B | 3.54B | 2.73B | 2.73B |
| Investing Cash Flow | -951.00M | -100.00M | -418.00M | -785.00M | -1.06B |
| Financing Cash Flow | -2.18B | -3.17B | -2.37B | -1.76B | -1.70B |
Kimberly Clark Technical Analysis
Negative
96.60
Price Trends
101.82
Negative
101.12
Negative
111.01
Negative
Market Momentum
-1.47
Negative
43.58
Neutral
71.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KMB, the sentiment is Negative. The current price of 96.6 is below the 20-day moving average (MA) of 97.84, below the 50-day MA of 101.82, and below the 200-day MA of 111.01, indicating a bearish trend. The MACD of -1.47 indicates Negative momentum. The RSI at 43.58 is Neutral, neither overbought nor oversold. The STOCH value of 71.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KMB.
Kimberly Clark Risk Analysis
Kimberly Clark disclosed 26 risk factors in its most recent earnings report. Kimberly Clark reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Kimberly Clark Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $337.35B | 20.05 | 31.23% | 2.92% | 1.23% | 17.97% | |
73 Outperform | $22.60B | 27.62 | 17.16% | 1.38% | 1.45% | 42.04% | |
69 Neutral | $127.30B | 11.85 | 26.01% | 3.74% | -0.30% | -14.60% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $32.29B | 16.63 | 155.28% | 5.03% | -10.04% | -23.41% | |
61 Neutral | $67.60B | ― | 431.59% | 2.67% | -0.05% | 2.49% | |
56 Neutral | $12.73B | 19.52 | 1502.49% | 5.05% | -9.35% | 123.06% |
* Consumer Defensive Sector Average
KMB
Kimberly Clark
96.60
-38.85
-28.68%
CHD
Church & Dwight
95.03
-8.69
-8.38%
CLX
Clorox
103.39
-30.58
-22.82%
CL
Colgate-Palmolive
83.98
-8.01
-8.71%
PG
Procter & Gamble
143.58
-20.39
-12.44%
UL
Unilever
58.23
-6.19
-9.61%
Kimberly Clark Corporate Events
Business Operations and StrategyM&A TransactionsShareholder Meetings
Kimberly-Clark Shareholders Approve Kenvue Acquisition Plan
Positive
Jan 29, 2026
At virtual special meetings on January 29, 2026, Kimberly-Clark and Kenvue shareholders overwhelmingly approved the stock issuance and merger agreement underlying Kimberly-Clark’s planned acquisition of Kenvue, with 96% of K-C votes cast bac...
Legal ProceedingsM&A TransactionsRegulatory Filings and ComplianceShareholder Meetings
Kimberly-Clark updates merger proxy amid shareholder lawsuits
Negative
Jan 16, 2026
Kimberly-Clark and Kenvue, which signed a merger agreement on November 2, 2025, have progressed their planned two-step merger structure, with the SEC declaring effective on December 16, 2025, a registration statement covering Kimberly-Clark shares...
Business Operations and StrategyM&A Transactions
Kimberly-Clark Announces Joint Venture with Suzano
Neutral
Dec 4, 2025
Kimberly-Clark Corporation announced on June 5, 2025, a strategic joint venture with Suzano S.A. for its International Family Care and Professional segment, marking a significant operational shift. The transaction, expected to close in mid-2026, i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.